XPhyto Therapeutics Corp.

Recent News

  • XPhyto Therapeutics Enters Exclusive Cannabis Research and Development Agreement with the Technical University of Munich

    Vancouver, British Columbia--(Newsfile Corp. - August 14, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), has entered into an exclusive cannabis research and development agreement (the "R&D Agreement") with the department ...

    2019-08-14 9:00 AM ET
  • XPhyto Therapeutics Commences Trading on the Frankfurt Stock Exchange

    Vancouver, British Columbia--(Newsfile Corp. - August 13, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares have commenced trading today on the Frankfurt Stock Exchange (the "FSE") under the ticker symbol "4XT"."Given XPhyto's German cannabis licence and its commitment to ...

    2019-08-13 11:52 AM ET
  • XPhyto Therapeutics Commences Trading on the CSE

    Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares will commence trading today on the Canadian Securities Exchange (the "CSE") under the ticker symbol "XPHY"."Trading on the CSE is a significant corporate milestone ...

    2019-08-06 8:30 AM ET
  • XPhyto Therapeutics Receives German Cannabis Licence for Scientific Cultivation and Extraction

    Vancouver, British Columbia--(Newsfile Corp. - July 24, 2019) - XPhyto Therapeutics Corp. ("XPhyto" or the "Company") is pleased to announce that the German Federal Institute for Drugs and Medical Devices ("BfArM") has granted XPhyto's wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), a cannabis cultivation and extraction licence for scientific ...

    2019-07-24 6:00 AM ET